Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5

Topical agents, such as microbicides, that can protect against human immunodeficiency virus (HIV) transmission are urgently needed. Using a chimeric simian/human immunodeficiency virus (SHIV SF162), which is tropic for the chemokine receptor CCR5, we report that topical application of high doses of PSC-RANTES, an amino terminus–modified analog of the chemokine RANTES, provided potent protection against vaginal challenge in rhesus macaques. These experimental findings have potentially important implications for understanding vaginal transmission of HIV and the design of strategies for its prevention.

[1]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[2]  V. KewalRamani,et al.  Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Brookmeyer,et al.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda , 2001, The Lancet.

[4]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[5]  John P. Moore,et al.  Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120 , 2003, Nature Medicine.

[6]  Jean Salamero,et al.  HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.

[7]  R. Doms,et al.  HIV Transmission , 2004, The Journal of experimental medicine.

[8]  J. Orenstein,et al.  Candidate Microbicides Block HIV-1 Infection of Human Immature Langerhans Cells within Epithelial Tissue Explants , 2000, The Journal of experimental medicine.

[9]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[10]  M. Lederman,et al.  R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Á. McKnight,et al.  Cell surface receptors, virus entry and tropism of primate lentiviruses. , 2002, The Journal of general virology.

[12]  M. Locati,et al.  HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. , 1997, Virology.

[13]  Douglas S Kwon,et al.  DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.

[14]  K. Gustafson,et al.  Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. , 2004, AIDS research and human retroviruses.

[15]  B. Cullen,et al.  Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor , 1997, The EMBO journal.

[16]  A. Haase,et al.  Transmission, acute HIV-1 infection and the quest for strategies to prevent infection , 2003, Nature Medicine.

[17]  P. Debré,et al.  Human Immunodeficiency Virus Type 1 Entry Inhibitors Selected on Living Cells from a Library of Phage Chemokines , 2003, Journal of Virology.

[18]  M. Mack,et al.  Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.

[19]  O. Chaloin,et al.  Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression , 2001, Journal of Virology.

[20]  T. Schwartz,et al.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.

[21]  J. Goedert,et al.  Characterization of high-risk HIV-1 seronegative hemophiliacs. , 2001, Clinical immunology.

[22]  B. M. Flynn,et al.  Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment , 2001, Journal of Virology.

[23]  E. Arts,et al.  Variable Sensitivity of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates to Inhibition by RANTES Analogs , 2000, Journal of virology.

[24]  F. Galimi,et al.  Two Mechanisms for Human Immunodeficiency Virus Type 1 Inhibition by N-Terminal Modifications of RANTES , 2003, Antimicrobial Agents and Chemotherapy.

[25]  Hassan Mohammad Naif,et al.  HIV gp120 receptors on human dendritic cells. , 2001, Blood.

[26]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[27]  Pascal Poignard,et al.  Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants , 1999, Journal of Virology.

[28]  R. Doms,et al.  Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection , 2003, The Journal of experimental medicine.

[29]  Christopher J. Miller,et al.  Target cells in vaginal HIV transmission. , 2003, Microbes and infection.